NCT04721145View on ClinicalTrials.gov

CGM Use in Poorly Controlled Youth With Type 1 Diabetes

NACompletedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

January 25, 2021

Primary Completion Date

June 28, 2022

Study Completion Date

June 28, 2022

Conditions
Type 1 DiabetesHypoglycemiaHigh Blood Sugar
Interventions
DEVICE

Dexcom G6 Continuous Glucose Monitor

Eligible patients will have a Dexcom G6 Continuous Glucose Monitor placed for 10 days.

Trial Locations (1)

21287

Johns Hopkins Pediatric Diabetes Center, Baltimore

All Listed Sponsors
collaborator

DexCom, Inc.

INDUSTRY

lead

Johns Hopkins University

OTHER

NCT04721145 - CGM Use in Poorly Controlled Youth With Type 1 Diabetes | Biotech Hunter | Biotech Hunter